Mar 11, 2019 Takeda Canada announces positive results for ENTYVIO® (vedolizumab) vs. Humira® (adalimumab) in first IBD study to compare biological agents head-to-head Learn moreEn savoir plus
Dec 10, 2018 Connecting patients with specialists in rural and remote communities Learn moreEn savoir plus
Nov 27, 2018 Remembering Cam Lyster, and the seriousness of inflammatory bowel disease Learn moreEn savoir plus
Nov 1, 2018 The 2018 Impact of Inflammatory Bowel Disease in Canada Report, and Crohn’s and Colitis Awareness Month Learn moreEn savoir plus